| RS2141506264 |
KRAS
|
Health Risk |
Pathogenic |
— |
| RS2141509652 |
KRAS
|
Health Risk |
Likely pathogenic |
Noonan syndrome 3, Noonan syndrome 3 |
| RS2141509708 |
KRAS
|
Health Risk |
Likely pathogenic |
Venous malformation, Venous malformation |
| RS2141509791 |
KRAS
|
Health Risk |
Likely pathogenic |
— |
| RS2141509883 |
KRAS
|
Health Risk |
Likely pathogenic |
RASopathy, Noonan syndrome 3 |
| RS2141509932 |
KRAS
|
Health Risk |
Pathogenic |
Capillary Telangiectasia, Brain |
| RS2141509973 |
KRAS
|
Health Risk |
Pathogenic |
Noonan syndrome 3, Noonan syndrome 3 |
| RS2141523598 |
PLIN1
|
Health Risk |
Pathogenic |
PLIN1-related familial partial lipodystrophy, PLIN1-related familial partial lipodystrophy |
| RS2141525540 |
PLIN1
|
Health Risk |
Pathogenic |
PLIN1-related familial partial lipodystrophy, PLIN1-related familial partial lipodystrophy |
| RS2141531787 |
ETFA
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2141540660 |
IFT140
|
Health Risk |
Pathogenic/Likely pathogenic |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS2141540743 |
SIN3A
|
Health Risk |
Pathogenic |
— |
| RS2141540759 |
SIN3A
|
Health Risk |
Pathogenic |
SIN3A-related intellectual disability syndrome due to a point mutation, SIN3A-related intellectual disability syndrome due to a point mutation |
| RS2141541431 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2141541516 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2141543695 |
ETFA
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2141554930 |
ALDH1A3
|
Health Risk |
Pathogenic |
Isolated microphthalmia 8, Isolated microphthalmia 8 |
| RS2141556264 |
ALPK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2141556375 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2141556442 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2141556463 |
ALPK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2141556552 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2141556595 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2141557313 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS2141557520 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2141563800 |
ACAN
|
Health Risk |
Likely pathogenic |
Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans |
| RS2141563841 |
ACAN
|
Health Risk |
Pathogenic |
Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans |
| RS2141566255 |
BRF1
|
Health Risk |
Likely pathogenic |
Cerebellar-facial-dental syndrome, Cerebellar-facial-dental syndrome |
| RS2141566449 |
ACAN
|
Health Risk |
Likely pathogenic |
— |
| RS2141567039 |
ALPK3
|
Health Risk |
Likely pathogenic |
— |
| RS2141567062 |
ACAN
|
Health Risk |
Likely pathogenic |
Osteochondritis dissecans, Osteochondritis dissecans |
| RS2141567430 |
ALPK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, Cardiovascular phenotype |
| RS2141567598 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2141567846 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2141567902 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS2141568082 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS2141568088 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2141568204 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2141568242 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2141568675 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2141568790 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2141569005 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS2141569048 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2141569123 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2141569401 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS2141570234 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2141570246 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2141570299 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS2141570684 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2141570935 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2141570949 |
ALPK3
|
Health Risk |
Likely pathogenic |
— |
| RS2141570994 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2141571783 |
SIN3A
|
Health Risk |
Pathogenic |
— |
| RS2141572840 |
ALPK3
|
Health Risk |
Likely pathogenic |
— |
| RS2141573290 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS2141573395 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2141574028 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2141575644 |
ALPK3
|
Health Risk |
Likely pathogenic |
— |
| RS2141576691 |
ACAN
|
Health Risk |
Pathogenic |
Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans |
| RS2141576820 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS2141576857 |
ACAN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2141577390 |
ACAN
|
Health Risk |
Likely pathogenic |
— |
| RS2141581633 |
ACAN
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia, Kimberley type |
| RS2141581781 |
ACAN
|
Health Risk |
Pathogenic/Likely pathogenic |
Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans |
| RS2141581981 |
ACAN
|
Health Risk |
Likely pathogenic |
— |
| RS2141582868 |
ACAN
|
Health Risk |
Pathogenic |
Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans |
| RS2141585529 |
ACAN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2141585993 |
ACAN
|
Health Risk |
Pathogenic |
Osteochondritis dissecans, Osteochondritis dissecans |
| RS2141587294 |
ACAN
|
Health Risk |
Pathogenic |
Osteochondritis dissecans, Short stature and advanced bone age |
| RS2141587301 |
ACAN
|
Health Risk |
Pathogenic |
Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans |
| RS2141587447 |
ACAN
|
Health Risk |
Likely pathogenic |
Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans |
| RS2141587692 |
ACAN
|
Health Risk |
Likely pathogenic |
— |
| RS2141596294 |
ACAN
|
Health Risk |
Likely pathogenic |
— |
| RS2141600468 |
ADAMTS17
|
Health Risk |
Likely pathogenic |
Weill-Marchesani 4 syndrome, recessive |
| RS2141602054 |
ACAN
|
Health Risk |
Likely pathogenic |
— |
| RS2141602321 |
ACAN
|
Health Risk |
Likely pathogenic |
— |
| RS2141606910 |
ACAN
|
Health Risk |
Pathogenic |
Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans |
| RS2141608062 |
ACAN
|
Health Risk |
Likely pathogenic |
Osteochondritis dissecans, Osteochondritis dissecans |
| RS2141610121 |
ACAN
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2141611557 |
ACAN
|
Health Risk |
Pathogenic |
Osteochondritis dissecans, Osteochondritis dissecans |
| RS2141613985 |
ACAN
|
Health Risk |
Likely pathogenic |
Short stature, Short stature |
| RS2141619663 |
ERCC4
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group F |
| RS2141630590 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2141631138 |
GRIN2A
|
Health Risk |
Likely pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2141631426 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2141631751 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2141631923 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2141632382 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2141632418 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2141632749 |
GNPTG
|
Health Risk |
Likely pathogenic |
GNPTG-mucolipidosis, Familial cancer of breast |
| RS2141632937 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2141633130 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2141633312 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2141634877 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2141638307 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS2141642686 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS2141643269 |
TBC1D2B
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with seizures and gingival overgrowth, Neurodevelopmental disorder with seizures and gingival overgrowth |
| RS2141643586 |
TBC1D2B
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with seizures and gingival overgrowth, Neurodevelopmental disorder with seizures and gingival overgrowth |
| RS2141648298 |
UMOD
|
Health Risk |
Likely pathogenic |
— |
| RS2141653795 |
LRRK1
|
Health Risk |
Pathogenic |
Osteosclerotic metaphyseal dysplasia, Osteosclerotic metaphyseal dysplasia |